Promega

Promega Broadens Forensic Portfolio Through Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits

Promega Expands Forensic Portfolio with Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits Forensic casework laboratories will now have access to NimaGen’s IDseek® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced today between the two…

Read MorePromega Broadens Forensic Portfolio Through Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits
Arrowhead

Compass Pathways Launches U.S. Grant Program to Develop Post-Approval COMP360 Provider Training

Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training Compass Pathways plc a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced an invitation for U.S. based organizations to apply…

Read MoreCompass Pathways Launches U.S. Grant Program to Develop Post-Approval COMP360 Provider Training
Travere

Travere Therapeutics Secures Full FDA Approval for FILSPARI® (sparsentan), the First and Only Treatment for FSGS

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…

Read MoreTravere Therapeutics Secures Full FDA Approval for FILSPARI® (sparsentan), the First and Only Treatment for FSGS
Forlong Biotechnology

Genialis Supermodel Forecasts Patient Response to HER2-Targeted Therapy Enhertu

Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu Genialis, the therapeutic intelligence company, announced it will present the first results from a new AI-based algorithm designed to distinguish between patients more likely to benefit from treatment with trastuzumab deruxtecan (Enhertu®, T-DXd).…

Read MoreGenialis Supermodel Forecasts Patient Response to HER2-Targeted Therapy Enhertu
Thermo Fisher

Thermo Fisher Scientific’s PPD Clinical Research Unit Partners with HealthVerity to Enhance Real-World Data Capabilities

Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance…

Read MoreThermo Fisher Scientific’s PPD Clinical Research Unit Partners with HealthVerity to Enhance Real-World Data Capabilities
Quiver Bioscience

Quiver Bioscience Secures Strategic Investment from the Porta Family to Advance UBE3A ASO Therapy for Dup15q Syndrome

Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome Quiver Bioscience a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, today announced…

Read MoreQuiver Bioscience Secures Strategic Investment from the Porta Family to Advance UBE3A ASO Therapy for Dup15q Syndrome
Transcat

Transcat Enters Latin American Market with Acquisition of SCM Metrology and Laboratories S.A.

Transcat Expands into Latin America with Acquisition of SCM Metrology and Laboratories S.A. Transcat, Inc. a leading provider of test measurement, control and calibration, announced the acquisition of SCM Metrology and Laboratories S.A. (“SCM”), a privately-held calibration services provider based…

Read MoreTranscat Enters Latin American Market with Acquisition of SCM Metrology and Laboratories S.A.
ADDING

ADDING MULTIMEDIA: Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer

ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective…

Read MoreADDING MULTIMEDIA: Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer
Booz Allen

Booz Allen Hamilton advances orbital warfare capabilities for the space domain

Booz Allen Advances Orbital Warfare for Space Domain Booz Allen Hamilton announced that its corporate venture capital arm, Booz Allen Ventures, has invested in Portal Space Systems, a U.S.-based space technology company developing rapidly maneuverable spacecraft for next-generation orbital operations. Portal Space Systems…

Read MoreBooz Allen Hamilton advances orbital warfare capabilities for the space domain